Nasal application of rBet v 1 or non–IgE-reactive T-cell epitope–containing rBet v 1 fragments has different effects on systemic allergen-specific antibody responses - 07/08/11

Supported by grants SFB F1803, F1815, F1818 and L214-B13 of the Austrian Science Fund (FWF) and by the Christian Doppler Research Association, Vienna, Austria. |
|
Disclosure of potential conflict of interest: S. Vrtala has received research support from FWF Austrian Science Fund. R. Valenta has received research support from FWF Austrian Science Fund and the Christian Doppler Research Association and is a consultant for Biomay, Vienna, Austria, and for Phadia, Uppsala, Sweden. V. Niederberger has received research support from the Austrian Science Fund. The rest of the authors have declared that they have no conflict of interest. |
Vol 126 - N° 6
P. 1312 - décembre 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?